At a time when FDA reform is in the air - the Clinton administration is poised to announce significant reforms and Congress will take up the issue in a few weeks - the workings of FDA advisory panels should also be on the table.

Advisory committee meetings are seminal events, often marking the defining moment in the perception of a company's science, its value and overall credibility.